Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Pharmaceutical Industry
Oncology
Biotechnology
Market Research
Lifesciences
Clinical Development
Market Access
Biopharmaceuticals
Business Analysis
Drug Discovery
Neurology
Market Analysis
Pharmaceutical Sales
Drug Development
Technology Transfer
Global Marketing
Sales Effectiveness
Competitive Intelligence
Cardiology
Clinical Trials
Education
Lists including Martin
Investments
Vedanta Biosciences
Series E
Total Funding: $110M
BioVersys
Series C
Total Funding: $9M
Venatorx Pharmaceuticals
Series C
Total Funding: $76M
Adaptive Phage Therapeutics
Series B
Total Funding: $61M
Libra Therapeutics
Series A
Total Funding: $29M
Rgenta Therapeutics
Seed
Total Funding: $90M
Sentien Biotechnologies
Series A
Total Funding: $12M
Sentieon
Series A
Total Funding: $4M
ArmaGen Technologies
Series A
Total Funding: $17M
Work Experience
2020
Chief Investment Officer
2021
Member Board of Directors AMR action
2020 - 2021
2020
Board Member MassBio Biotechnology
2020
2020 - 2021
Member Board of Directors Libra Therapeutics Inc.
2020 - 2021
2020 - 2021
Member Board of Directors Tiga Tx Inc.
2020 - 2021
2020 - 2021
Member Board of Directors Rgenta Therapeutics Inc.
2020 - 2021
2016 - 2021
Member Board of Directors Abexxa Biologics Inc.
2016 - 2021
2015 - 2021
Member Board of Directors
2015 - 2021
2013 - 2021
Managing Director BIVF USA Inc.
2013 - 2021
Run Boehringer Ingelheim Venture Fund offices in the United States, scout for early investment opportunities in Cambridge and other sites of innovation and lead respective Due Diligence, invest in start-up biotech companies and represent BIVF US as a Board Director.
2012 - 2020
Member Board of Directors
2012 - 2020
2014 - 2016
Member Board of Directors
2014 - 2016